Open Access
Open Access (OA) refers to the practice of providing unrestricted access via the Internet to peer-reviewed scholarly research. Open access comes in two degrees: Gratis Open Access, which is free online access, and Libre Open Access, which is free online access plus some additional usage rights. These additional usage rights are often granted through the use of various specific Creative Commons licenses. Open access can be applied to all forms of published research output, including peer-reviewed and non peer-reviewed academic journal articles, conference papers, theses, book chapters, and monographs.
History[edit | edit source]
The open access movement began in the 1990s, as part of a wider movement for open content, to democratize access to knowledge. It gained an important boost from the Budapest Open Access Initiative, an international effort to make research articles in all academic fields freely available on the internet.
Types of Open Access[edit | edit source]
There are two main types of open access: Green Open Access and Gold Open Access. Green Open Access, also referred to as self-archiving, is the practice of placing a version of an author's manuscript into a repository, making it freely accessible for everyone. Gold Open Access, on the other hand, involves the publication of articles in open access journals. In this case, the publisher makes all articles and related content available for free immediately on the journal's website.
Benefits[edit | edit source]
Open Access has several benefits. It removes price barriers (subscriptions, licensing fees, pay-per-view fees) and permission barriers (most copyright and licensing restrictions). The Public Library of Science and BioMed Central are prominent examples of this model.
Criticisms[edit | edit source]
Despite the benefits, Open Access has also faced criticism. Some critics claim that open access journals do not have a rigorous peer review process, leading to the publication of lower quality papers. Others worry about the sustainability of open access publishers who charge no fees to readers or libraries.
See Also[edit | edit source]
| Open Access Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
